See also this year's filing and all EDGAR filings for this company.
PDF Report 0001625288_2023_Nexien_Biopharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001625288, Nexien Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 124,518 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 0 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 242,123 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 530,762 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 33,230 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -62,365 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 124,518 |
| 1 | Liabilities | 242,123 |
| 2 | Expenses | 563,992 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -117,605 |
| 5 | NetIncome | -626,357 |
| 6 | ComprehensiveNetIncome | -626,357 |
| 7 | BaseVar | 496,499 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.82 |
| 9 | EconomicCapitalRatio | 0.221 |
Edgar->Model Mapping
Feature Distribution
Change over Time
